In addition, ADPKD patients who had received kidney transplants were observed to have reduced volumes of affected kidney and liver if an mTOR inhibitor was included in the immunosuppressive regimen (Shillingford et al., 2006; Qian et al., 2008). This evidence concerns the gene MTOR and autosomal dominant polycystic kidney disease.